meridol is owned by Colgate-Palmolive (the United States, NYSE: CL), which acquired the brand on 1 May 2004.[1][2] meridol was founded in 1990 in Switzerland and was independent until 2004.
meridol is a gum care toothpaste sold through European pharmacies, formulated with amine fluoride and stannous fluoride. Colgate-Palmolive acquired it with the Swiss GABA business in 2004. Amine fluoride spreads across the tooth surface more readily than sodium fluoride, which is the basis of the brand's clinical positioning.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Colgate-Palmolive ownership tree →
Colgate-Palmolive acquired GABA Holding, a Swiss oral care company selling elmex and meridol through European pharmacies. The purchase gave Colgate a pharmacy channel and a specialist reputation in Europe that its mass-market toothpaste could not reach on its own. The price was not disclosed.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
The parent company of meridol is Colgate-Palmolive, a publicly listed company headquartered in the United States.
meridol originated in Switzerland in 1990, but it is owned today by Colgate-Palmolive, which is headquartered in the United States. So meridol is a Swiss-origin brand under American ownership.
Colgate-Palmolive completed its acquisition of meridol on 1 May 2004, after announcing the deal on 1 March 2004.
meridol was an independent company from its founding in 1990 until Colgate-Palmolive acquired it in 2004.
Yes. As of 8 September 2026, meridol is still owned by Colgate-Palmolive. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.